- Home
- ORGO vs CBNK Comparison
ORGO vs CBNK Comparison
Compare ORGO & CBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- CBNK
- Stock Information
- Founded
- ORGO 1985
- CBNK 1974
- Country
- ORGO United States
- CBNK United States
- Employees
- ORGO N/A
- CBNK N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- CBNK Major Banks
- Sector
- ORGO Health Care
- CBNK Finance
- Exchange
- ORGO Nasdaq
- CBNK Nasdaq
- Market Cap
- ORGO 539.1M
- CBNK 501.8M
- IPO Year
- ORGO N/A
- CBNK 2018
- Fundamental
- Price
- ORGO $3.97
- CBNK $28.23
- Analyst Decision
- ORGO Buy
- CBNK Buy
- Analyst Count
- ORGO 3
- CBNK 2
- Target Price
- ORGO $7.33
- CBNK $36.00
- AVG Volume (30 Days)
- ORGO 717.2K
- CBNK 46.5K
- Earning Date
- ORGO 11-06-2025
- CBNK 10-27-2025
- Dividend Yield
- ORGO N/A
- CBNK 1.70%
- EPS Growth
- ORGO N/A
- CBNK 26.24
- EPS
- ORGO N/A
- CBNK 2.95
- Revenue
- ORGO $429,531,000.00
- CBNK $222,152,000.00
- Revenue This Year
- ORGO $2.51
- CBNK $45.32
- Revenue Next Year
- ORGO $25.45
- CBNK $6.34
- P/E Ratio
- ORGO N/A
- CBNK $9.58
- Revenue Growth
- ORGO N/A
- CBNK 40.71
- 52 Week Low
- ORGO $2.61
- CBNK $24.69
- 52 Week High
- ORGO $6.71
- CBNK $36.40
- Technical
- Relative Strength Index (RSI)
- ORGO 40.52
- CBNK 36.94
- Support Level
- ORGO $3.84
- CBNK $27.29
- Resistance Level
- ORGO $4.30
- CBNK $29.89
- Average True Range (ATR)
- ORGO 0.18
- CBNK 0.66
- MACD
- ORGO 0.00
- CBNK 0.00
- Stochastic Oscillator
- ORGO 23.64
- CBNK 33.63
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About CBNK Capital Bancorp Inc.
Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage, and also operates in five business segments: commercial banking; mortgage banking; credit cards; government loan servicing; and corporate activities.